Literature DB >> 404432

Autoradiographic and histopathologic studies on the mode of action of an aromatic retinoid (Ro 10-9359) on chemically induced epithelial tumors in Swiss mice.

M Frigg, J Torhorst.   

Abstract

The mode of action of an aromatic analogue of retinoic acid, ethyl all-trans-9-(4-methoxy-2,3,6-trimethyl-phenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoate (Ro 10-9359), a compound known to possess a considerable prophylactic and therapeutic effect on skin papillomas and carcinomas, was investigated with autoradiographic and histopathologic methods. The ip application of a single dose of 1,000 mg Ro 10-9359/kg to female Swiss mice with chemically induced skin papillomas caused a 29% regression of the mean tumor diameter after 3 days and a 51% regression after 7 days. In the tumors, the number of DNA-synthesizing cells [measured by the labeling index (LI)] and the length of the cell cycle were not affected by the retinoid; thus a mode of action at the level of cell proliferation can be excluded. In the normal skin, an increase in the LI of about 30% was observed. A small effect on the cell loss was observed; however, it was not sufficient to explain quantitatively the regression of the tumors. When measured histometrically, it appeared that the loss of the horn and the formation of necroses, 3-10 times larger than in the placebo groups, were mainly responsible for the tumor regressions caused by the retinoid. After 7 days, the proportion of stroma in the tumors was increased, and dilation of the vessels and edema in the stroma proximal to the necroses were frequent.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 404432     DOI: 10.1093/jnci/58.5.1365

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  7 in total

1.  [Pachydermia of the larynx--treatment with the aromatic retinoid (Ro 10-9359) (author's transl)].

Authors:  E Bichler; H Spoendlin
Journal:  Arch Otorhinolaryngol       Date:  1979

Review 2.  Inhibition of carcinogenesis by retinoids.

Authors:  P Nettesheim
Journal:  Can Med Assoc J       Date:  1980-04-05       Impact factor: 8.262

Review 3.  Retinoids, a new class of compounds with prophylactic and therapeutic activities in oncology and dermatology.

Authors:  H Mayer; W Bollag; R Hänni; R Rüegg
Journal:  Experientia       Date:  1978-09-15

4.  Lack of enhancement of experimental photocarcinogenesis by topical retinoic acid.

Authors:  L H Kligman; A M Kligman
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

Review 5.  Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

Review 6.  Retinoids and cancer.

Authors:  W Bollag
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

7.  Reinitiation of DNA synthesis in quiescent mouse keratinocytes; regulation by polypeptide hormones, cholera toxin, dexamethasone, and retinoic acid.

Authors:  M Reiss; C L Dibble
Journal:  In Vitro Cell Dev Biol       Date:  1988-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.